Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective.
作者信息
Patidar Kavish R, Piano Salvatore, Cullaro Giuseppe, Belcher Justin M, Allegretti Andrew S
机构信息
Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana.
Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padova, Italy.
出版信息
Clin Gastroenterol Hepatol. 2023 Apr;21(4):897-901.e1. doi: 10.1016/j.cgh.2022.12.034. Epub 2023 Feb 18.
Abstract
摘要
相似文献
1
Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective.肝肾综合征管理的最新进展：美国视角
Clin Gastroenterol Hepatol. 2023 Apr;21(4):897-901.e1. doi: 10.1016/j.cgh.2022.12.034. Epub 2023 Feb 18.
2
[Research advances in pathophysiology and diagnosis and treatment of hepatorenal syndrome].肝肾综合征的病理生理学及诊断与治疗研究进展
Zhonghua Gan Zang Bing Za Zhi. 2017 Apr 20;25(4):246-248. doi: 10.3760/cma.j.issn.1007-3418.2017.04.002.
3
[The therapy of the hepatorenal syndrome in liver cirrhosis].[肝硬化患者肝肾综合征的治疗]
Dtsch Med Wochenschr. 1999 Sep 10;124(36):1039-42. doi: 10.1055/s-2007-1024479.
4
The hepatorenal syndrome.肝肾综合征
Med Clin North Am. 2008 Jul;92(4):813-37, viii-ix. doi: 10.1016/j.mcna.2008.03.007.
5
[Hepatorenal syndrome: terminal stage of major complicances of hepatic cirrhosis].肝肾综合征：肝硬化主要并发症的终末期
Clin Ter. 2004 Sep;155(9):361-2.
6
[Hepatorenal syndrome in patients with liver cirrhosis].[肝硬化患者的肝肾综合征]
Nephrol Ther. 2005 Jul;1(3):174-82. doi: 10.1016/j.nephro.2005.03.002. Epub 2005 May 31.
7
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.肝硬化肝肾综合征的诊断、预防及治疗
Gut. 2007 Sep;56(9):1310-8. doi: 10.1136/gut.2006.107789. Epub 2007 Mar 27.
8
Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.肝硬化患者急性静脉曲张出血和肝肾综合征的诊断和初步处理建议。
Dig Dis Sci. 2019 Jun;64(6):1419-1431. doi: 10.1007/s10620-018-5448-y. Epub 2019 Jan 25.
9
Hepatorenal syndrome.肝肾综合征
Dis Mon. 2016 Oct;62(10):364-375. doi: 10.1016/j.disamonth.2016.05.009. Epub 2016 Jun 29.
10
[Clinical analysis of 38 patients with hepatorenal syndrome].38例肝肾综合征患者的临床分析
Zhonghua Gan Zang Bing Za Zhi. 2003 Oct;11(10):628.
引用本文的文献
1
Applying Metabolomics and Aptamer-based Proteomics to Determine Pathophysiologic Differences in Decompensated Cirrhosis Patients Hospitalized with Acute Kidney Injury.应用代谢组学和适体蛋白质组学确定因急性肾损伤住院的失代偿期肝硬化患者的病理生理差异。
Res Sq. 2024 May 9:rs.3.rs-4344179. doi: 10.21203/rs.3.rs-4344179/v1.
2
From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury.从过去到现在再到未来：特利加压素与肝肾综合征 - 急性肾损伤
Hepatology. 2025 Jun 1;81(6):1878-1897. doi: 10.1097/HEP.0000000000000790. Epub 2024 Feb 14.
本文引用的文献
1
Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury.尿中性粒细胞明胶酶相关脂质运载蛋白在肝硬化伴急性肾损伤患者中的诊断和预后性能。
Hepatology. 2023 May 1;77(5):1630-1638. doi: 10.1002/hep.32799. Epub 2023 Apr 17.
2
Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure.特利加压素在 1 型肝肾综合征和严重急性慢性肝衰竭患者中的应用与呼吸衰竭。
Aliment Pharmacol Ther. 2022 Oct;56(8):1284-1293. doi: 10.1111/apt.17195. Epub 2022 Aug 22.
3
Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study.尿中性粒细胞明胶酶相关脂质运载蛋白（NGAL）作为肝硬化急性肾损伤的诊断和预后标志物：一项前瞻性研究。
Clin Transl Gastroenterol. 2021 May 11;12(5):e00359. doi: 10.14309/ctg.0000000000000359.
4
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.腹水、自发性细菌性腹膜炎和肝肾综合征的诊断、评估及管理：美国肝病研究协会2021年实践指南
Hepatology. 2021 Aug;74(2):1014-1048. doi: 10.1002/hep.31884.
5
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.特利加压素联合白蛋白治疗 1 型肝肾综合征。
N Engl J Med. 2021 Mar 4;384(9):818-828. doi: 10.1056/NEJMoa2008290.
6
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.欧洲肝脏研究学会失代偿期肝硬化患者管理临床实践指南
J Hepatol. 2018 Aug;69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10.
7
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.急慢性肝衰竭程度与肝肾综合征患者特利加压素和白蛋白反应的关系。
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1792-1800.e3. doi: 10.1016/j.cgh.2018.01.035. Epub 2018 Jan 31.
8
Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis.尿素分数排泄率：肝硬化急性肾损伤鉴别诊断的简单工具。
Hepatology. 2018 Jul;68(1):224-233. doi: 10.1002/hep.29772. Epub 2018 May 17.
9
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.在OT - 0401和REVERSE随机临床研究的汇总分析中，特利加压素联合白蛋白与安慰剂联合白蛋白治疗1型肝肾综合征的疗效对比
Aliment Pharmacol Ther. 2017 Jun;45(11):1390-1402. doi: 10.1111/apt.14052. Epub 2017 Mar 29.
10
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.肝硬化患者急性肾损伤的诊断与管理：国际腹水俱乐部修订的共识建议
Gut. 2015 Apr;64(4):531-7. doi: 10.1136/gutjnl-2014-308874. Epub 2015 Jan 28.
Zotero 插件